Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-29T08:29:40.067Z Has data issue: false hasContentIssue false
  • English
  • Français

The Pharmaco-economics of Schizophrenia: New Horizons

Published online by Cambridge University Press:  16 April 2020

K.J. Aitchison  and
R.W. Kerwin
K.J. Aitchison
Affiliation:
Section of Clinical Neuropharmacology, Dept Psychological Medicine, Institute of Psychiatry, De Crespigny Park, Denmark HillSE5 8AF
R.W. Kerwin
Affiliation:
Section of Clinical Neuropharmacology, Dept Psychological Medicine, Institute of Psychiatry, De Crespigny Park, Denmark HillSE5 8AF

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Information
European Psychiatry , Volume 11 , Issue S4: European psychiatry: a force for the future - 8th Congress of Association of European Psychiatrists and Annual Meeting of the Royal College of Psychiatrists , 1996 , pp. 225s
Copyright
Copyright © Elsevier Paris 1996

References

[1] Smith K, etal.Brit J Psychiat 1995,166,9-18.CrossRefGoogle Scholar
[2] Kane JM. Brit J Psychiat 1992, 160(suppl 17),41-45.CrossRefGoogle Scholar
[3] Meltzer HY. Eur Psychiat 1995,10(suppl 1), 19s-25s.CrossRefGoogle Scholar
[4] Chouinard G. et al, J Clin Psychophannacol 1993, 12,25-40.Google Scholar
Submit a response

Comments

No Comments have been published for this article.